Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Preda, Lorenzo ^a   Calloni, Sonia Francesca ^a   Moscatelli, Marco Elvio Manlio ^a   Cossu Rocca, Maria ^b   Bellomi, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; DIAGNOSTIC IMAGING; FEASIBILITY STUDY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; REVIEW; SCINTIGRAPHY; TREATMENT RESPONSE; VASCULAR TUMOR; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK TUMOR; MAGNETIC RESONANCE ANGIOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); PROCEDURES; RADIOGRAPHY; SQUAMOUS CELL CARCINOMA; VASCULARIZATION;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; NEOVASCULARIZATION, PATHOLOGIC; PERFUSION IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84927170930     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/917150     Document Type: Review

References (33)

1. H. S. van Monsjou, A. J. M. Balm, M. M. van den Brekel, and V. B. Wreesmann, "Oropharyngeal squamous cell carcinoma: a unique disease on the rise" Oral Oncology, vol. 46, no. 11, pp. 780-785, 2010.
2. A. A. Forastiere, H. Goepfert, and M. Maor, "Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer, " The New England Journal of Medicine, vol. 349, pp. 2091-2098, 2003.
3. J. Ma, Y. Liu, X. Huang et al. , "Induction chemotherapy decreases the rate of distantmetastasis in patientswith head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis, " Oral Oncology, vol. 48, no. 11, pp. 1076-1084, 2012.
4. L. J. Wirth and M. R. Posner, "Recent advances in combined modality therapy for locally advanced head and neck cancer, " Current Cancer Drug Targets, vol. 7, no. 7, pp. 674-680, 2007.
5. J. B. Vermorken, R. S. Herbst, X. Leon, N. Amellal, and J. Baselga, "Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies, " Cancer, vol. 112, no. 12, pp. 2710-2719, 2008.
6. J. A. Bonner, P. M. Harari, J. Giralt et al. , "Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck, " The New England Journal of Medicine, vol. 354, no. 6, pp. 567-578, 2006.
7. J. B. Vermorken, E. Remenar, C. van Herpen et al. , "Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer, "TheNew England Journal ofMedicine, vol. 357, pp. 1695-1704, 2007.
8. M. T. Truong, N. Saito, A. Ozonoff et al. , "Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy, " The American Journal of Neuroradiology, vol. 32, no. 7, pp. 1195-1201, 2011.
9. G. Petralia, L. Preda, G. Giugliano et al. , "Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: Correlation between changes in tumor perfusion and tumor volume, " Journal of Computer Assisted Tomography, vol. 33, no. 4, pp. 552-559, 2009.
10. D. Gandhi, D. B. Chepeha, T. Miller et al. , "Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy, " American Journal of Neuroradiology, vol. 27, no. 1, pp. 101-106, 2006.
11. K. S. Surlan-PopovѤc, S. Bisdas, Z. Rumboldt, T. S. Koh, and P. Strojan, "Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy, " American Journal of Neuroradiology, vol. 31, no. 3, pp. 570-575, 2010.
12. R. Hermans, M. Meijerink, W. van den Bogaert, A. Rijnders, C. Weltens, and P. Lambin, "Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy, " International Journal of Radiation Oncology Biology Physics, vol. 57, no. 5, pp. 1351-1356, 2003.
13. A. Zima, R. Carlos, D. Gandhi, I. Case, T. Teknos, and S. K. Mukherji, "Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy, " American Journal of Neuroradiology, vol. 28, no. 2, pp. 328-334, 2007.
14. S. Bisdas, Z. Rumboldt, J. Wagenblast et al. , "Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements, " The American Journal of Neuroradiology, vol. 30, no. 4, pp. 793-799, 2009.
15. S. Bisdas, S. A. Nguyen, S. K. Anand, G. Glavina, T. Day, and Z. Rumboldt, "Outcome prediction chemoradiation of in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume, " International Journal of Radiation Oncology? Biology? Physics, vol. 73, no. 5, pp. 1313-1318, 2009.
16. S. Bisdas, Z. Rumboldt, K. Surlan-Popovic et al. , "Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements, " American Journal of Neuroradiology, vol. 31, no. 3, pp. 576-581, 2010.
17. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al. , "New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute ofCanada, " Journal of theNationalCancer Institute, vol. 92, no. 3, pp. 205-216, 2000.
18. L. Preda, E. Lovati, F. Chiesa et al. , "Measurement by multidetector CT scan of the volume of hypopharyngeal and laryngeal tumours: accuracy and reproducibility, " European Radiology, vol. 17, no. 8, pp. 2096-2102, 2007.
19. R. Hermans, K. Op de Beeck, W. van den Bogaert et al. , "The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment, " International Journal of Radiation Oncology, Biology, Physics, vol. 50, no. 1, pp. 37-45, 2001.
20. A. Srinivasan, S. Mohan, and S. K. Mukherji, "Biologic imaging of head and neck cancer: the present and the future, " American Journal of Neuroradiology, vol. 33, no. 4, pp. 586-594, 2012.
21. A. M. Tawfik, A. A. Razek, L. G. Elsorogy et al. , "Perfusion CT of head and neck cancer, " European Journal of Radiology, vol. 83, no. 3, pp. 537-544, 2014.
22. G. Petralia, L. Preda, G. DAndrea et al. , "CT perfusion in solidbody tumours. Part I: technical issues, " Radiologia Medica, vol. 115, no. 6, pp. 843-857, 2010.
23. G. Petralia, L. Bonello, S. Viotti, L. Preda, G. DAndrea, and M. Bellomi, "CT perfusion in oncology: how to do it, " Cancer Imaging, vol. 10, no. 1, pp. 8-19, 2010.
24. A. M. Tawfik, A. A. Abdel Razek, L. G. Elsorogy et al. , "Perfusion CT of head and neck cancer: effect of arterial input selection, " American Journal of Roentgenology, vol. 196, no. 6, pp. 1374-1380, 2011.
25. G. Petralia, L. Preda, S. Raimondi et al. , "Intra andinterobserver agreement and impact of arterial input selection in perfusion CT measurements performed in squamous cell carcinoma of the upper aerodigestive tract, " The American Journal of Neuroradiology, vol. 30, no. 6, pp. 1107-1115, 2009.
26. K. A. Miles, "Perfusion CT for the assessment of tumour vascularity: which protocol" British Journal of Radiology, vol. 76, no. 1, pp. S36-S42, 2003.
27. A. R. Kambadakone and D. V. Sahani, "Body perfusion CT: technique, clinical applications, and advances, " Radiologic Clinics of North America, vol. 47, no. 1, pp. 161-178, 2009.
28. V. Goh, S. Halligan, A. Gharpuray, D. Wellsted, J. Sundin, and C. I. Bartram, "Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest, " Radiology, vol. 247, no. 3, pp. 726-732, 2008.
29. M. Bellomi, S. Viotti, L. Preda, G. DAndrea, L. Bonello, and G. Petralia, "Perfusion CT in solid body-tumours. Part II: clinical applications and future development, " La Radiologia Medica, vol. 115, no. 6, pp. 858-874, 2010.
30. V. K. Gupta, N. T. Jaskowiak, M. A. Beckett et al. , "Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance, " Cancer Journal, vol. 8, no. 1, pp. 47-54, 2002.
31. T. Martone, P. Rosso, R. Albera et al. , "Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome, " Oral Oncology, vol. 41, no. 2, pp. 147-155, 2005.
32. K. P. Claffey, L. F. Brown, L. F. Del Aguila et al. , "Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis, " Cancer Research, vol. 56, no. 1, pp. 172-181, 1996.
33. H. Axelson, E. Fredlund, M. Ovenberger, G. Landberg, and S. Påhlman, "Hypoxia-induced dedifferentiation of tumor cells-a mechanism behind heterogeneity and aggressiveness of solid tumors, " Seminars in Cell andDevelopmental Biology, vol. 16, no. 4-5, pp. 554-563, 2005.